Upstream Bio (UPB) Gross Margin (2024 - 2026)

Upstream Bio's (UPB) quarterly Gross Margin came in at 380.95% in Q1 2026, down 10480.0% year-on-year from N/an in Q1 2025, and up 66.84% quarter-over-quarter from 1148.8% in Q4 2025.

Upstream Bio (UPB) Gross Margin (2024 - 2026) Analysis & Trends

Upstream Bio's Gross Margin history runs 3 years deep, the most recent figure standing at 380.95% for Q1 2026.

  • On a quarterly basis, Gross Margin fell 10480.0% year-over-year to 380.95% in Q1 2026; TTM through Mar 2026 was 678.36%, a 40884.0% decrease from a year earlier, with the FY2025 full-year figure at 706.34%, down 52870.0% from the prior year.
  • Gross Margin rose to 380.95% in Q1 2026 per UPB's latest filing, from 1148.8% in the prior quarter.
  • Across five years, Gross Margin topped out at 45.16% in Q1 2024 and bottomed at 1148.8% in Q4 2025.
  • The 3-year median for Gross Margin is 276.15% (2025), against an average of 420.78%.
  • Biggest YoY gain for Gross Margin was 1320 bps in 2025; the steepest drop was 79856 bps in 2025.
  • Year by year, Gross Margin stood at 350.24% in 2024, then plunged by 228 bps to 1148.8% in 2025, then surged by 67 bps to 380.95% in 2026.
  • Per Business Quant, the three latest UPB Gross Margin figures stand at 380.95% (Q1 2026), 1148.8% (Q4 2025), and 272.18% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Oculis Holding AG 66,079.99 Bn 66,079.71 Bn - -
2 Nanobiotix 1,912.79 Bn 1,912.73 Bn - -
3 Akari Therapeutics 1,022.34 Bn 1,022.34 Bn - -
4 BeOne Medicines 471.68 Bn 466.89 Bn 1.35 Bn 88.95%
5 Vertex Pharmaceuticals 122.31 Bn 115.06 Bn 2.59 Bn 86.85%
6 Regeneron Pharmaceuticals 70.24 Bn 61.49 Bn 3.31 Bn 91.79%
7 Belite Bio 63.01 Bn 63.01 Bn - -
8 Argenx Se 56.02 Bn 50.83 Bn 1.41 Bn 90.68%
9 Alnylam Pharmaceuticals 37.46 Bn 34.45 Bn 959.66 Mn 82.22%
10 Upstream Bio 350.44 Mn 350.44 Mn -3.94 Mn -380.95%

Historic Data

Download Data
DateValue
Mar 31, 2026 -380.95%
Dec 31, 2025 -1,148.80%
Sep 30, 2025 -272.18%
Jun 30, 2025 -967.24%
Mar 31, 2025 -276.15%
Dec 31, 2024 -350.24%
Sep 30, 2024 -258.98%
Jun 30, 2024 -177.65%
Mar 31, 2024 45.16%